Efficacy and safety of adjuvant immunoadsorption in pemphigus vulgaris and pemphigus foliaceus (IA-Pem Study): a multicentre randomised controlled trial

CONCLUSIONS: In this study, adjuvant IA did not show a shorter time to clinical remission but a corticosteroid-sparing effect. In patients with extensive PV/PF, post hoc analysis suggests that adjuvant IA may possibly lead to earlier remission, but potential adverse events must be carefully weighed against the expected benefits.PMID:38133541 | DOI:10.1093/bjd/ljad489

Source: The British Journal of Dermatology - December 22, 2023 Category: Dermatology Authors: Nina van Beek R üdiger Eming Alexander Reuss Detlef Zillikens Mikl ós Sárdy Claudia G ünther Dimitra Kiritsi Sandrine Benoit Stefan Beissert Regine Gl äser Harald Gollnick Orsolya N Horv áth Christiane Pfeiffer Martin R öcken Franziska Schauer Step Source Type: research